Health authorities in Australia have confirmed the nation's first death from diphtheria in over thirty years, marking a grim milestone in an outbreak that is rapidly escalating across Queensland. The victim, a young child from the state's far north, died from respiratory complications caused by the bacterial toxin, according to a statement released by Queensland Health on Tuesday evening. The case brings the total number of confirmed infections in the current outbreak to 47, a figure that has more than doubled in the past fortnight.
Diphtheria, a vaccine-preventable disease caused by *Corynebacterium diphtheriae*, was once a leading cause of childhood mortality before widespread immunisation programmes largely eradicated it from developed nations. The bacterium produces a potent exotoxin that can cause a thick grey pseudomembrane to form in the throat, leading to airway obstruction, cardiac arrhythmias, and multi-organ failure. Mortality rates hover near 5 to 10 percent even with antitoxin and antibiotic therapy.
The outbreak is concentrated among Indigenous communities in remote regions of Queensland, where vaccination coverage has fallen below the herd immunity threshold. The Australian Immunisation Register data shows that only 72 percent of children in the affected area have received the full primary course of the diphtheria-tetanus-pertussis vaccine, well short of the 90 percent target. Contributing factors include geographic isolation, vaccine hesitancy, and disruptions to routine healthcare during the COVID-19 pandemic.
Queensland's Chief Health Officer Dr. John Gerrard described the situation as deeply concerning. 'This is a disease of poverty and under-immunisation. We are witnessing a preventable tragedy unfolding in real time,' he said at a press conference. Health teams are scrambling to conduct door-to-door vaccination drives and administer prophylactic antibiotics to close contacts of known cases. However, the remoteness of the communities and a shortage of public health nurses are hampering efforts.
The diphtheria toxoid vaccine confers protection by neutralising the toxin but does not prevent colonisation or transmission. This means that even vaccinated individuals can carry and spread the bacterium, complicating outbreak control. Additionally, the current vaccine formulation does not cover the closely related *Corynebacterium ulcerans*, which can also produce diphtheria toxin and has been isolated from some cases in this outbreak.
The Australian government has allocated emergency funding for an intensified vaccination campaign and the procurement of additional doses of diphtheria antitoxin from the national stockpile. The antitoxin, derived from equine serum, must be administered intravenously as early as possible to neutralise circulating toxin. With global supplies constrained due to declining production, Australia's reserve is sufficient for an estimated 100 cases.
This outbreak mirrors recent resurgences of vaccine-preventable diseases in other high-income countries where immunisation gaps have widened. The World Health Organization recorded 8,648 diphtheria cases globally in 2022, a 30 percent increase from the previous year. Conflict zones and regions with low vaccination coverage in Yemen, Indonesia, and Haiti have seen large-scale epidemics.
The tragedy is a stark reminder that pathogens do not respect borders or development indices. A disease that was consigned to the history books in Australia has resurfaced with lethal consequences, a direct result of systemic failures in public health infrastructure and vaccine equity. As the outbreak spirals, every day of delay in mounting a comprehensive response risks further loss of life.
